• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

评估三药联合在胰腺癌细胞中的药效学相互作用。

Assessment of Three-Drug Combination Pharmacodynamic Interactions in Pancreatic Cancer Cells.

机构信息

Department of Pharmaceutical Sciences, School of Pharmacy and Pharmaceutical Sciences, University at Buffalo, State University of New York, Buffalo, New York, 14214, USA.

Ciblage Thérapeutique en Oncologie, Faculté de médecine Lyon-sud, Université Lyon 1, 69921, Oullins, France.

出版信息

AAPS J. 2018 Jun 27;20(5):80. doi: 10.1208/s12248-018-0235-4.

DOI:10.1208/s12248-018-0235-4
PMID:29951754
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7218410/
Abstract

The pharmacodynamic interactions among trifluoperazine (TFP), gemcitabine (GEM), and paclitaxel (PTX) were assessed in pancreatic cancer cells (PANC-1). The phenothiazine TFP was chosen for its potential activity on cancer stem cells, while GEM and PTX cause apoptosis. Effects of each drug alone and in various combinations on cell growth inhibition of PANC-1 cells were studied in vitro to determine the drug-specific parameters and assess the nature of drug interactions. Joint inhibition (JI) and competitive inhibition (CI) equations were applied with a ψ interaction term. TFP fully inhibited growth of cells (I = 1) with an IC = 9887 nM. Near-maximum inhibition was achieved for GEM (I = 0.825) and PTX (I= 0.844) with an IC = 17.4 nM for GEM and IC = 7.08 nM for PTX. Estimates of an interaction term ψ revealed that the combination of TFP-GEM was apparently synergistic; close to additivity, the combination TFP-PTX was antagonistic. The interaction of GEM-PTX was additive, and TFP-GEM-PTX was synergistic but close to additive. The combination of TFP IC-GEM IC-PTX IC seemed optimal in producing inhibition of PANC-1 cells with an inhibitory effect of 82.1-90.2%. The addition of ψ terms to traditional interaction equations allows assessment of the degree of perturbation of assumed mechanisms.

摘要

在胰腺癌细胞(PANC-1)中评估了三氟拉嗪(TFP)、吉西他滨(GEM)和紫杉醇(PTX)之间的药效学相互作用。选择吩噻嗪 TFP 是因为它对癌症干细胞具有潜在的活性,而 GEM 和 PTX 则引起细胞凋亡。在体外研究每种药物单独和各种组合对 PANC-1 细胞生长抑制的影响,以确定药物的特异性参数并评估药物相互作用的性质。应用联合抑制(JI)和竞争抑制(CI)方程,并加入 ψ 相互作用项。TFP 完全抑制细胞生长(I=1),IC=9887 nM。GEM(I=0.825)和 PTX(I=0.844)接近最大抑制,IC=17.4 nM 用于 GEM 和 IC=7.08 nM 用于 PTX。相互作用项 ψ 的估计表明,TFP-GEM 组合显然是协同的;接近加性,TFP-PTX 组合是拮抗的。GEM-PTX 的相互作用是相加的,而 TFP-GEM-PTX 是协同的,但接近加性。TFP IC-GEM IC-PTX IC 的组合似乎是抑制 PANC-1 细胞的最佳组合,抑制作用为 82.1-90.2%。在传统的相互作用方程中添加 ψ 项可以评估对假定机制的干扰程度。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4de8/7218410/da0128dfb8cf/nihms-1582422-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4de8/7218410/ff5a3bd2811c/nihms-1582422-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4de8/7218410/0b5f3601b05c/nihms-1582422-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4de8/7218410/8dee55585719/nihms-1582422-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4de8/7218410/8885d5a1763c/nihms-1582422-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4de8/7218410/d1348b7511d6/nihms-1582422-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4de8/7218410/da0128dfb8cf/nihms-1582422-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4de8/7218410/ff5a3bd2811c/nihms-1582422-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4de8/7218410/0b5f3601b05c/nihms-1582422-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4de8/7218410/8dee55585719/nihms-1582422-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4de8/7218410/8885d5a1763c/nihms-1582422-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4de8/7218410/d1348b7511d6/nihms-1582422-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4de8/7218410/da0128dfb8cf/nihms-1582422-f0006.jpg

相似文献

1
Assessment of Three-Drug Combination Pharmacodynamic Interactions in Pancreatic Cancer Cells.评估三药联合在胰腺癌细胞中的药效学相互作用。
AAPS J. 2018 Jun 27;20(5):80. doi: 10.1208/s12248-018-0235-4.
2
Use of a lipid-coated mesoporous silica nanoparticle platform for synergistic gemcitabine and paclitaxel delivery to human pancreatic cancer in mice.使用脂质包被的介孔二氧化硅纳米颗粒平台将吉西他滨和紫杉醇协同递送至小鼠的人胰腺癌中。
ACS Nano. 2015;9(4):3540-57. doi: 10.1021/acsnano.5b00510. Epub 2015 Mar 31.
3
Drug interactions and cytotoxic effects of paclitaxel in combination with carboplatin, epirubicin, gemcitabine or vinorelbine in breast cancer cell lines and tumor samples.紫杉醇与卡铂、表柔比星、吉西他滨或长春瑞滨联合使用在乳腺癌细胞系和肿瘤样本中的药物相互作用及细胞毒性作用。
Breast Cancer Res Treat. 2001 Jun;67(3):223-33. doi: 10.1023/a:1017980411398.
4
Synergistic Pharmacodynamic Effects of Gemcitabine and Fibroblast Growth Factor Receptor Inhibitors on Pancreatic Cancer Cell Cycle Kinetics and Proliferation.吉西他滨与成纤维细胞生长因子受体抑制剂对胰腺癌细胞周期动力学和增殖的协同药效学作用。
J Pharmacol Exp Ther. 2021 Jun;377(3):370-384. doi: 10.1124/jpet.120.000412. Epub 2021 Mar 22.
5
Synthesis of a gemcitabine-modified phospholipid and its subsequent incorporation into a single microbubble formulation loaded with paclitaxel for the treatment of pancreatic cancer using ultrasound-targeted microbubble destruction.合成一种修饰有吉西他滨的磷脂,并将其随后掺入到一种载紫杉醇的单微泡制剂中,用于使用超声靶向微泡破坏技术治疗胰腺癌。
Eur J Pharm Biopharm. 2021 Aug;165:374-382. doi: 10.1016/j.ejpb.2021.05.018. Epub 2021 May 24.
6
Gemcitabine enhances the transport of nanovector-albumin-bound paclitaxel in gemcitabine-resistant pancreatic ductal adenocarcinoma.吉西他滨增强纳米载体结合白蛋白紫杉醇在吉西他滨耐药性胰腺导管腺癌中的转运。
Cancer Lett. 2017 Sep 10;403:296-304. doi: 10.1016/j.canlet.2017.06.026. Epub 2017 Jul 4.
7
New treatment strategy with nuclear factor-κB inhibitor for pancreatic cancer.采用核因子-κB抑制剂治疗胰腺癌的新策略
J Surg Res. 2016 Nov;206(1):1-8. doi: 10.1016/j.jss.2016.06.047. Epub 2016 Jun 25.
8
Sequence-dependent synergism and antagonism between paclitaxel and gemcitabine in breast cancer cells: the importance of scheduling.紫杉醇与吉西他滨在乳腺癌细胞中的序列依赖性协同作用和拮抗作用:给药方案的重要性。
Int J Oncol. 2008 Jan;32(1):113-20.
9
Chemosensitization and inhibition of pancreatic cancer stem cell proliferation by overexpression of microRNA-205.通过过表达微小RNA-205实现胰腺癌干细胞的化学增敏作用及增殖抑制
Cancer Lett. 2017 Aug 28;402:1-8. doi: 10.1016/j.canlet.2017.05.007. Epub 2017 May 20.
10
Superior therapeutic efficacy of nab-paclitaxel over cremophor-based paclitaxel in locally advanced and metastatic models of human pancreatic cancer.在人胰腺癌局部晚期和转移模型中,纳米白蛋白结合型紫杉醇对比基于聚氧乙烯蓖麻油的紫杉醇具有更高的治疗效果。
Br J Cancer. 2016 Aug 9;115(4):442-53. doi: 10.1038/bjc.2016.215. Epub 2016 Jul 21.

引用本文的文献

1
Translational PK-PD/TD modeling of antitumor effects and peripheral neuropathy in gemcitabine and nab-paclitaxel chemotherapy from xenograft mice to patients for optimal dose and schedule.从异种移植小鼠到患者的吉西他滨和白蛋白结合型紫杉醇化疗的抗肿瘤作用和周围神经病变的翻译 PK-PD/TD 建模,以优化剂量和方案。
Cancer Chemother Pharmacol. 2024 Apr;93(4):365-379. doi: 10.1007/s00280-023-04625-5. Epub 2023 Dec 20.
2
First-Line Combination Treatment with Low-Dose Bipolar Drugs for ABCB1-Overexpressing Drug-Resistant Cancer Populations.一线联合应用低剂量双相药物治疗 ABCB1 过表达耐药性肿瘤人群。
Int J Mol Sci. 2023 May 7;24(9):8389. doi: 10.3390/ijms24098389.
3

本文引用的文献

1
Microfluidic co-culture of pancreatic tumor spheroids with stellate cells as a novel 3D model for investigation of stroma-mediated cell motility and drug resistance.微流控共培养胰腺肿瘤球体与星状细胞作为一种新型的 3D 模型用于研究基质介导的细胞迁移和耐药性。
J Exp Clin Cancer Res. 2018 Jan 12;37(1):4. doi: 10.1186/s13046-017-0654-6.
2
A general pharmacodynamic interaction model identifies perpetrators and victims in drug interactions.一般药效动力学相互作用模型可识别药物相互作用中的肇事者和受害者。
Nat Commun. 2017 Dec 14;8(1):2129. doi: 10.1038/s41467-017-01929-y.
3
A NOTCH-sensitive uPAR-regulated oncolytic adenovirus effectively suppresses pancreatic tumor growth and triggers synergistic anticancer effects with gemcitabine and nab-paclitaxel.
Pharmacodynamics and Bactericidal Activity of Combination Regimens in Pulmonary Tuberculosis: Application to Bedaquiline-Pretomanid-Pyrazinamide.
肺结核联合用药方案的药效学和杀菌活性:贝达喹啉-普托马尼-吡嗪酰胺的应用
Antimicrob Agents Chemother. 2022 Dec 20;66(12):e0089822. doi: 10.1128/aac.00898-22. Epub 2022 Nov 15.
4
FOLFIRINOX Pharmacodynamic Interactions in 2D and 3D Pancreatic Cancer Cell Cultures.二维和三维胰腺癌细胞培养物中 FOLFIRINOX 的药效学相互作用。
AAPS J. 2022 Oct 13;24(6):108. doi: 10.1208/s12248-022-00752-8.
5
From GWAS to drug screening: repurposing antipsychotics for glioblastoma.从 GWAS 到药物筛选:重新利用抗精神病药治疗神经胶质瘤。
J Transl Med. 2022 Feb 4;20(1):70. doi: 10.1186/s12967-021-03209-2.
6
Experimental and computational assessment of the synergistic pharmacodynamic drug-drug interactions of a triple combination therapy in refractory HER2-positive breast cancer cells.难治性HER2阳性乳腺癌细胞三联联合疗法协同药效学药物-药物相互作用的实验与计算评估
J Pharmacokinet Pharmacodyn. 2022 Apr;49(2):227-241. doi: 10.1007/s10928-021-09795-4. Epub 2021 Nov 13.
7
Synergistic Pharmacodynamic Effects of Gemcitabine and Fibroblast Growth Factor Receptor Inhibitors on Pancreatic Cancer Cell Cycle Kinetics and Proliferation.吉西他滨与成纤维细胞生长因子受体抑制剂对胰腺癌细胞周期动力学和增殖的协同药效学作用。
J Pharmacol Exp Ther. 2021 Jun;377(3):370-384. doi: 10.1124/jpet.120.000412. Epub 2021 Mar 22.
8
A quantitative systems pharmacological approach identified activation of JNK signaling pathway as a promising treatment strategy for refractory HER2 positive breast cancer.一种定量系统药理学方法将 JNK 信号通路的激活确定为一种有前途的治疗HER2 阳性乳腺癌耐药的策略。
J Pharmacokinet Pharmacodyn. 2021 Apr;48(2):273-293. doi: 10.1007/s10928-020-09732-x. Epub 2021 Jan 3.
9
Pharmacodynamic Drug-Drug Interactions.药效学药物-药物相互作用。
Clin Pharmacol Ther. 2019 Jun;105(6):1395-1406. doi: 10.1002/cpt.1434. Epub 2019 Apr 26.
一种Notch敏感的uPAR调节的溶瘤腺病毒可有效抑制胰腺肿瘤生长,并与吉西他滨和纳米白蛋白结合紫杉醇引发协同抗癌作用。
Oncotarget. 2017 Apr 4;8(14):22700-22715. doi: 10.18632/oncotarget.15169.
4
Cancer Stem Cells: Cellular Plasticity, Niche, and its Clinical Relevance.癌症干细胞:细胞可塑性、微环境及其临床相关性。
J Stem Cell Res Ther. 2016 Oct;6(10). doi: 10.4172/2157-7633.1000363. Epub 2016 Oct 26.
5
Assessment of non-linear combination effect terms for drug-drug interactions.药物相互作用的非线性组合效应项评估。
J Pharmacokinet Pharmacodyn. 2016 Oct;43(5):461-79. doi: 10.1007/s10928-016-9490-0. Epub 2016 Sep 16.
6
Generation of an in vitro 3D PDAC stroma rich spheroid model.体外3D富含胰腺导管腺癌基质的球体模型的构建。
Biomaterials. 2016 Nov;108:129-42. doi: 10.1016/j.biomaterials.2016.08.041. Epub 2016 Sep 2.
7
Co-Expression of Cancer Stem Cell Markers Corresponds to a Pro-Tumorigenic Expression Profile in Pancreatic Adenocarcinoma.癌症干细胞标志物的共表达与胰腺腺癌中的促肿瘤发生表达谱相对应。
PLoS One. 2016 Jul 14;11(7):e0159255. doi: 10.1371/journal.pone.0159255. eCollection 2016.
8
Pharmacodynamic modeling of combined chemotherapeutic effects predicts synergistic activity of gemcitabine and trabectedin in pancreatic cancer cells.联合化疗效果的药效学模型预测吉西他滨和曲贝替定在胰腺癌细胞中的协同活性。
Cancer Chemother Pharmacol. 2016 Jan;77(1):181-93. doi: 10.1007/s00280-015-2907-4. Epub 2015 Nov 25.
9
A concise review on the current understanding of pancreatic cancer stem cells.关于当前对胰腺癌干细胞认识的简要综述。
J Cancer Stem Cell Res. 2014;2. doi: 10.14343/jcscr.2014.2e1004.
10
Calmodulin antagonists promote TRA-8 therapy of resistant pancreatic cancer.钙调蛋白拮抗剂可促进TR-8对耐药性胰腺癌的治疗。
Oncotarget. 2015 Sep 22;6(28):25308-19. doi: 10.18632/oncotarget.4490.